Although this product is not sold in the u.S, this event is being reported under regulation 21 cfr part 803 as it involves a similar device to a pma approved device sold in the u.S.Under (b)(4).The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.As part of all complaint investigations, an attempt was made to evaluate the subject device as well as the device usage.In this case, no sample was returned.On the basis of the evaluation of the angiograms and images provided, a stent fracture can be confirmed.The outer surface of the relevant proximal stented part appeared homogenous with minor irregularities that could not be identified as fracture due to poor strut visibility.Potential factors that could have caused or contributed to the reported issue have been considered.Previous investigations of similar complaints have been reviewed.An irregular stent placement may lead or contribute to a subsequent stent fracture.An inadvertent movement of the hand or incorrect holding of the delivery system during stent release, an insufficient pre or post dilation as well as highly calcified vessels, the patients condition or the vessel anatomy may result in an irregular stent placement and subsequent stent fracture.Based on the information available and the evaluation of the images provided, a definite root cause for the event reported could not be determined.The ifu supplied with this product sufficiently describes the correct application of the device.
|